[Thoracic oncology]

Dtsch Med Wochenschr. 2011 Oct;136(40):2029-32. doi: 10.1055/s-0031-1286387. Epub 2011 Sep 28.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / diagnosis*
  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / mortality
  • Adenocarcinoma / pathology
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / pathology
  • Combined Modality Therapy
  • Cooperative Behavior*
  • Disease-Free Survival
  • Early Diagnosis
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / genetics
  • Humans
  • Interdisciplinary Communication*
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology
  • Neoplasm Staging
  • Palliative Care
  • Practice Guidelines as Topic
  • Precision Medicine
  • Prognosis
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • EGFR protein, human
  • ErbB Receptors